Problem 47 - Cliffs Test Prep NCLEX-RN

Question

Estrogen antagonists are used to treat estrogen hormone-dependent cancer, such as breast carcinoma. Androgen antagonists block testosterone stimulation of androgen-dependent cancers. An example of an androgen-dependent cancer would be: 1\. prostate cancer. 2\. thyroid cancer. 3\. renal carcinoma. 4\. neuroblastoma.

Step-by-Step Solution

Answer

The androgen-dependent cancer is prostate cancer (option 1).

Step 1: Understand the Question

The question is asking which type of cancer is an example of an androgen-dependent cancer, based on the information that androgen antagonists block testosterone stimulation of such cancers.

Step 2: Identify Androgen-Dependent Cancers

Androgen-dependent cancers rely on hormones like testosterone for growth. Prostate cancer is a well-known example of such cancers, as it often depends on androgen hormones for development and progression.

Step 3: Rule Out the Other Options

Consider the other cancer types: thyroid cancer, renal carcinoma, and neuroblastoma. These cancers are not typically androgen-dependent and do not primarily rely on testosterone for growth.

Step 4: Select the Correct Answer

Based on the analysis, prostate cancer (option 1) is the correct example of an androgen-dependent cancer, where androgen antagonists would be effective.

Key Concepts

Androgen Antagonists

Androgen antagonists are a class of drugs that work to block the effects of androgens, primarily testosterone, by binding to androgen receptors without activating them. This is crucial in managing androgen-dependent cancers, as these diseases rely on androgens for growth and survival. By reducing the influence of these hormones, androgen antagonists help slow down or even shrink these cancerous cells.

• These drugs come in various forms, including pills and injections.
• They are used not only for treatments of cancer but also for conditions like acne and hirsutism.

Common androgen antagonists include drugs like flutamide, bicalutamide, and enzalutamide. They work by attaching themselves to androgen receptors, preventing testosterone and other androgens from binding. This action is vital in combating cancer cases where the tumor growth is fueled by hormones such as testosterone.
Therefore, by using androgen antagonists, the goal is to effectively contest the cancer cell's need for androgen stimulus, facilitating better management of cancers that rely on these hormones.

Prostate Cancer

Prostate cancer is one of the most common types of cancer among men. It primarily targets the prostate gland, a small walnut-shaped gland that produces seminal fluid in men. This form of cancer is significantly noteworthy because of its dependency on androgens such as testosterone.

• Prostate cancer cells often use testosterone as a growth signal.
• Because of this dependency, androgen antagonists are frequently employed in treatment protocols.

Without testosterone and other similar hormones, prostate cancer cells find it challenging to thrive and propagate. For this reason, androgen deprivation therapy (ADT), which often includes the use of androgen antagonists, has become a staple component in treating certain stages of prostate cancer. By blocking testosterone, not only does the growth of cancer cells slow down, but it can also lead to the reduction in the size of the tumor.
Targeting testosterone levels can substantially improve outcomes for patients with prostate cancer and remains a pivotal strategy in its treatment.

Hormone-dependent Cancer

Hormone-dependent cancers are a category of cancers that require certain hormones to grow and proliferate. In these cancers, hormones act as a food source or growth signal for the cancer cells, making hormone management a crucial part of treatment.

• Androgens are one type associated with cancers like prostate cancer.
• Estrogens are another type related to conditions such as breast cancer.

Treatment strategies often involve hormone therapy to either lower the body's natural hormone production or block the effects of these hormones at the receptor level. This may include the use of hormone-blocking drugs like androgen antagonists for prostate cancer or estrogen antagonists for breast cancer.
Effective targeting of hormone pathways in these cancers can limit the resources that cancer cells need for growth, leading to better management and control of the disease. Understanding the hormone dependency of a cancer type is key to choosing the accurate treatment approach.